neurodegenerative disease
C2N Wins $1.5M Grant From Michael J Fox Foundation to Study Links Between Neurodegenerative Diseases
The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.
Abbott, Fujirebio Partner on Neurology Biomarker Assay
The companies are developing a research-use-only test for neurofilament-light chain for use on Abbott's Alinity I instrument.
The firm's test measures three biomarkers to determine whether a patient has Alzheimer's disease or another form of dementia.
RetinalGenix Technologies Acquires DNA/GPS
The deal gives RetinalGenix rights to DNA/GPS's retinal imaging and genetic mapping technology for patient screening and early diagnosis.
Biomarker-Based Dx for Alzheimer's Rise as Study Results Question Effectiveness in Different Races
Premium
A paper published last month found that blood-based biomarkers used in diagnostic tests for Alzheimer's may not work as well in African American patients.